These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 21170533)

  • 1. Beta cells under attack: toward a better understanding of type 1 diabetes immunopathology.
    Coppieters KT; Roep BO; von Herrath MG
    Semin Immunopathol; 2011 Jan; 33(1):1-7. PubMed ID: 21170533
    [No Abstract]   [Full Text] [Related]  

  • 2. Specific maternal microchimeric T cells targeting fetal antigens in β cells predispose to auto-immune diabetes in the child.
    Roy E; Leduc M; Guegan S; Rachdi L; Kluger N; Scharfmann R; Aractingi S; Khosrotehrani K
    J Autoimmun; 2011 May; 36(3-4):253-62. PubMed ID: 21414756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are T-cell responses to GAD65 influential in type 1 diabetes?
    Quinn A
    Diabetes; 2009 Dec; 58(12):2729-30. PubMed ID: 19940237
    [No Abstract]   [Full Text] [Related]  

  • 4. NF-κB in type 1 diabetes.
    Zhao Y; Krishnamurthy B; Mollah ZU; Kay TW; Thomas HE
    Inflamm Allergy Drug Targets; 2011 Jun; 10(3):208-17. PubMed ID: 21495968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention or acceleration of type 1 diabetes by viruses.
    Ghazarian L; Diana J; Simoni Y; Beaudoin L; Lehuen A
    Cell Mol Life Sci; 2013 Jan; 70(2):239-55. PubMed ID: 22766971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Causes of early-onset type 1 diabetes: toward data-driven environmental approaches.
    Bougnères P; Valleron AJ
    J Exp Med; 2008 Dec; 205(13):2953-7. PubMed ID: 19075294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond insulin: seeking a cure. Hurdles include halting an immune attack, replacing lost cells.
    Lyon L
    US News World Rep; 2008 Oct; 145(9):88. PubMed ID: 18998529
    [No Abstract]   [Full Text] [Related]  

  • 8. Disease-modifying immunotherapy for the management of autoimmune diabetes.
    Castro CN; Barcala Tabarrozi AE; Noguerol MA; Liberman AC; Dewey RA; Arzt E; Morelli AE; Perone MJ
    Neuroimmunomodulation; 2010; 17(3):173-6. PubMed ID: 20134195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. beta-Cells step up in controlling the autoimmune response.
    Fiorina P
    Diabetes; 2010 Aug; 59(8):1861-4. PubMed ID: 20668291
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunopathology of the human pancreas in type-I diabetes.
    Richardson SJ; Willcox A; Bone AJ; Morgan NG; Foulis AK
    Semin Immunopathol; 2011 Jan; 33(1):9-21. PubMed ID: 20424842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The case for an autoimmune aetiology of type 1 diabetes.
    Mannering SI; Pathiraja V; Kay TW
    Clin Exp Immunol; 2016 Jan; 183(1):8-15. PubMed ID: 26313217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic changes in pancreatic endocrine cell abundance, distribution, and function in antigen-induced and spontaneous autoimmune diabetes.
    Pechhold K; Zhu X; Harrison VS; Lee J; Chakrabarty S; Koczwara K; Gavrilova O; Harlan DM
    Diabetes; 2009 May; 58(5):1175-84. PubMed ID: 19228810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysrulation of T cell peripheral tolerance in type 1 diabetes.
    Tisch R; Wang B
    Adv Immunol; 2008; 100():125-49. PubMed ID: 19111165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioengineering strategies for inducing tolerance in autoimmune diabetes.
    Baekkeskov S; Hubbell JA; Phelps EA
    Adv Drug Deliv Rev; 2017 May; 114():256-265. PubMed ID: 28625830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-lymphocyte recognition of beta cells in type 1 diabetes: clinical perspectives.
    Boitard C
    Diabetes Metab; 2013 Dec; 39(6):459-66. PubMed ID: 24139825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A roadmap of the generation of neoantigens as targets of the immune system in type 1 diabetes.
    Roep BO; Kracht MJ; van Lummel M; Zaldumbide A
    Curr Opin Immunol; 2016 Dec; 43():67-73. PubMed ID: 27723537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The primacy of CD8 T lymphocytes in type 1 diabetes and implications for therapies.
    Faustman DL; Davis M
    J Mol Med (Berl); 2009 Dec; 87(12):1173-8. PubMed ID: 19693476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune Recognition of β-Cells: Neoepitopes as Key Players in the Loss of Tolerance.
    James EA; Pietropaolo M; Mamula MJ
    Diabetes; 2018 Jun; 67(6):1035-1042. PubMed ID: 29784651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural Killer Cells as Key Mediators in Type I Diabetes Immunopathology.
    Gardner G; Fraker CA
    Front Immunol; 2021; 12():722979. PubMed ID: 34489972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fulminant type 1 diabetes].
    Imagawa A; Hanafusa T
    Nihon Rinsho; 2006 Sep; Suppl 3():37-41. PubMed ID: 17022496
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.